Senate Finance Committee Chair Ron Wyden (D-OR) said there is “no question” that drug pricing will be an element of the Senate’s final budget resolution bill, and he again touted the idea of the government negotiating prices. “When you have 50 million citizens-plus on Medicare, the program ought to negotiate a good deal. Who in the world doesn't negotiate?” Wyden told reporters Wednesday (July 14). When asked whether drug pricing can be used as a pay-for like Senate Budget Chair...